Pharmacogenomics in the clinic

被引:564
作者
Relling, Mary V. [1 ]
Evans, William E. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
关键词
IMPLEMENTATION CONSORTIUM GUIDELINES; PERSONALIZED MEDICINE; ECONOMIC-EVALUATION; DECISION-SUPPORT; RESEARCH NETWORK; GENETIC-CONTROL; DRUG-REACTIONS; GENOTYPE; CYP2D6; GENOMICS;
D O I
10.1038/nature15817
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
After decades of discovery, inherited variations have been identified in approximately 20 genes that affect about 80 medications and are actionable in the clinic. And some somatically acquired genetic variants direct the choice of 'targeted' anticancer drugs for individual patients. Current efforts that focus on the processes required to appropriately act on pharmacogenomic variability in the clinic are moving away from discovery and towards implementation of an evidenced-based strategy for improving the use of medications, thereby providing a cornerstone for precision medicine.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 111 条
[21]   Role of phenotypic and genetic testing in managing clopidogrel therapy [J].
Chan, Noel C. ;
Eikelboom, John W. ;
Ginsberg, Jeffrey S. ;
Lauw, Mandy N. ;
Vanassche, Thomas ;
Weitz, Jeffrey I. ;
Hirsh, Jack .
BLOOD, 2014, 124 (05) :689-699
[22]   Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions [J].
Chen, Zhibin ;
Liew, Danny ;
Kwan, Patrick .
NEUROLOGY, 2014, 83 (22) :2077-2084
[23]   Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes [J].
Cheng, Q ;
Yang, WJ ;
Raimondi, SC ;
Pui, CH ;
Relling, MV ;
Evans, WE .
NATURE GENETICS, 2005, 37 (08) :878-882
[24]   Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance [J].
Cooper, David N. ;
Brand, Angela ;
Dolzan, Vita ;
Fortina, Paolo ;
Innocenti, Federico ;
Lee, Ming Ta Michael ;
Macek, Milan, Jr. ;
Al-Mulla, Fahd ;
Prainsack, Barbara ;
Squassina, Alessio ;
Vayena, Effy ;
Vozikis, Athanassios ;
Williams, Marc S. ;
Patrinos, George P. .
PERSONALIZED MEDICINE, 2014, 11 (07) :615-623
[25]   eMERGEing progress in genomics-the first seven years [J].
Crawford, Dana C. ;
Crosslin, David R. ;
Tromp, Gerard ;
Kullo, Iftikhar J. ;
Kuivaniemi, Helena ;
Hayes, M. Geoffrey ;
Denny, Joshua C. ;
Bush, William S. ;
Haines, Jonathan L. ;
Roden, Dan M. ;
McCarty, Catherine A. ;
Jarvik, Gail P. ;
Ritchie, Marylyn D. .
FRONTIERS IN GENETICS, 2014, 5
[26]   Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update [J].
Crews, K. R. ;
Gaedigk, A. ;
Dunnenberger, H. M. ;
Leeder, J. S. ;
Klein, T. E. ;
Caudle, K. E. ;
Haidar, C. E. ;
Shen, D. D. ;
Callaghan, J. T. ;
Sadhasivam, S. ;
Prows, C. A. ;
Kharasch, E. D. ;
Skaar, T. C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (04) :376-382
[27]   DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics [J].
Dalabira, Eleni ;
Viennas, Emmanouil ;
Daki, Elisavet ;
Komianou, Angeliki ;
Bartsakoulia, Marina ;
Poulas, Konstantinos ;
Katsila, Theodora ;
Tzimas, Giannis ;
Patrinos, George P. .
PUBLIC HEALTH GENOMICS, 2014, 17 (5-6) :265-271
[28]   Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers [J].
Dunnenberger, Henry M. ;
Crews, Kristine R. ;
Hoffman, James M. ;
Caudle, Kelly E. ;
Broeckel, Ulrich ;
Howard, Scott C. ;
Hunkler, Robert J. ;
Klein, Teri E. ;
Evans, William E. ;
Relling, Mary V. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 :89-+
[29]   Pharmacogenomic information in drug labels: European Medicines Agency perspective [J].
Ehmann, F. ;
Caneva, L. ;
Prasad, K. ;
Paulmichl, M. ;
Maliepaard, M. ;
Llerena, A. ;
Ingelman-Sundberg, M. ;
Papaluca-Amati, M. .
PHARMACOGENOMICS JOURNAL, 2015, 15 (03) :201-210
[30]   GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].
EVANS, DAP ;
MANLEY, KA ;
MCKUSICK, VA .
BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491